- Home
- /Cyclic citrullinated peptide Ab.IgG
Cyclic citrullinated peptide Ab.IgG
Detects antibodies targeting modified proteins found in inflamed joints.
Why This Biomarker Matters
Anti-CCP antibodies are highly specific for rheumatoid arthritis and predict joint damage. Early detection allows for early treatment to prevent permanent joint destruction.
Overview
Cyclic citrullinated peptide (anti-CCP) antibodies are proteins your immune system produces against specific components found in inflamed joints. This test detects these antibodies in blood or body fluid. Anti-CCP antibodies are highly specific for rheumatoid arthritis (RA) and can be present years before symptoms develop. A positive result suggests an increased risk of developing RA or indicates existing rheumatoid arthritis. This test is valuable for early diagnosis and predicting disease severity, enabling earlier treatment to prevent joint damage.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
33935-8Primary63217-442898-794874-5Available Lab Tests
Order tests that measure this biomarker